Revenue

AI data firm Hyperscale Data ties its fate to Bitcoin, with a treasury nearing its market value. A bold strategy or a risky gambit amid a major pivot?

New clinically aware AI agents offer empathetic, 24/7 patient support, aiming to reduce provider burnout and improve access to care for all.

Subsea 7 has landed a contract worth up to $300M for Chevron's Gorgon Stage 3 project, reinforcing its key role in Australia's deepwater energy sector.

Southchip posts its 11th straight quarter of revenue growth, but falling margins and a huge R&D spend reveal a bold, high-risk expansion strategy.

Beyond Nordic hype, Helsinki's compact size and collaborative spirit are fostering a unique, accessible, and innovative culinary scene on its own terms.

Zephyrus Innovations just got FDA clearance for VaporShield, a device protecting nurses from drug exposure. It’s a story of safety, market disruption, and efficiency.

ViaBill's Apple Pay integration brings new financing to Danish checkout, but this convenience arrives amid new regulations and a major strategy shift from Apple.

Ayrmid and RoslinCT forge a key manufacturing pact for a new SAA therapy, revealing the critical infrastructure needed for resilient biotech returns.

A new Google-TotalEnergies deal in Malaysia reveals the collision of a data boom and green energy goals, a key test for the region's strategic future.

Hexagon's latest acquisition of AI specialist IconPro signals a major push into predictive maintenance, aiming to redefine manufacturing efficiency.

Thailand is betting on a century-old Christmas parade, supercharged with AI and drones, to diversify its tourism empire and unlock new economic value.

After bombshell allegations and a stock plunge, Rezolve AI faces a major lawsuit investigation, raising critical questions about AI hype and corporate honesty.

MetaComp and Stable are building a compliant, high-speed payment network with stablecoins, aiming to disrupt the trillion-dollar cross-border market.

Affluent buyers in Southeast Asia are trading property for lifestyle, fueling a 230% boom in branded residences. Why is experience the new ultimate luxury?

A new healthcare city linked to China's largest western HSR hub promises to revolutionize medical access for millions, blending urban planning with wellness.

A breakthrough clinical trial and a savvy financial move could net Fractyl Health $18M to advance its novel obesity treatment beyond the GLP-1 boom.

A decade-long wait ends as the FDA approves a new 1st-line therapy for HER2+ breast cancer. See how ENHERTU reshapes patient outcomes and market dynamics.

A familiar quit-smoking app has been rebuilt into a powerful research tool, powering Australia's largest cessation trial and setting a new standard.

Biotech Immunome plans a massive stock offering. A deep dive into the high-stakes bet on its cancer pipeline and what it means for investors.

Boise Cascade's acquisition of Holden Humphrey aims to reshape the Northeast building materials market, consolidating its power and expanding its product lines.